Literature DB >> 1864716

Sclerosing peritonitis caused by disinfectant in a patient under peritoneal dialysis.

A Karátson1, I Buzogány, G Wágner, L Rácz.   

Abstract

An uraemic patient under intermittent peritoneal dialysis was found in the 9th month of treatment to present ultrafiltration drop and increase of low-molecular weight substances. Two instances of laparotomy for heavy abdominal bleeding revealed peritoneal thickening, laminar intestinal concrescence and diffuse haemorrhage. The patient died in the 13th month of treatment under symptoms of ileus. Other reasons excluded, sclerosing peritonitis was attributed to the formalin solution employed as disinfectant for the abdominal catheter. The causative factors are listed together with the chances of prevention.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864716     DOI: 10.1007/bf02549717

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  13 in total

1.  [Bacterial biofilms and medical practice].

Authors:  I Kétyi
Journal:  Orv Hetil       Date:  1989-11-12       Impact factor: 0.540

2.  Fluid and solute transport across the peritoneum during continuous ambulatory peritoneal dialysis (CAPD)

Authors:  R T Krediet; L Arisz
Journal:  Perit Dial Int       Date:  1989       Impact factor: 1.756

3.  Sclerosing encapsulating peritonitis in rats: an experimental study with intraperitoneal antiseptics.

Authors:  R C Mackow; J F Winchester; W P Argy; P M Andrews; P A Fields; S Bates; T A Rakowski; G E Schreiner
Journal:  Contrib Nephrol       Date:  1987       Impact factor: 1.580

Review 4.  Beta-adrenergic blockade and the gastrointestinal system.

Authors:  H Jacob; L J Brandt; P Farkas; W Frishman
Journal:  Am J Med       Date:  1983-06       Impact factor: 4.965

5.  Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study.

Authors:  A Slingeneyer; B Canaud; C Mion
Journal:  Nephron       Date:  1983       Impact factor: 2.847

6.  Infection of the abdominal cavity and chronic peritoneal dialysis.

Authors:  A Karátson; M F Dávid; L Farkas; B Kocsis; L Rácz
Journal:  Int Urol Nephrol       Date:  1981       Impact factor: 2.370

7.  Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol).

Authors:  P Brown; H Baddeley; A E Read; J D Davies; J McGarry
Journal:  Lancet       Date:  1974-12-21       Impact factor: 79.321

8.  Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients.

Authors:  V C Gandhi; H M Humayun; T S Ing; J T Daugirdas; V R Jablokow; S Iwatsuki; W P Geis; J E Hano
Journal:  Arch Intern Med       Date:  1980-09

9.  Case-control study to determine the cause of sclerosing peritoneal disease.

Authors:  R Oulès; S Challah; F P Brunner
Journal:  Nephrol Dial Transplant       Date:  1988       Impact factor: 5.992

10.  Sclerosing peritonitis with mural bowel fibrosis in a patient on long-term CAPD.

Authors:  D Hauglustaine; J van Meerbeek; J Monballyu; P Goddeeris; J Lauwerijns; P Michielsen
Journal:  Clin Nephrol       Date:  1984-09       Impact factor: 0.975

View more
  2 in total

Review 1.  Toxic effects of formaldehyde on the urinary system.

Authors:  Mehmet İnci; İsmail Zararsız; Mürsel Davarcı; Sadık Görür
Journal:  Turk J Urol       Date:  2013-03

2.  Peritoneal dialysis in Hungary.

Authors:  A Karátson; J Makó
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.